Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blanc

Showing results (181-190 of 195) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaP Rougier, A Adenis, M Ducreux, et al.
HIV Clinical Trials|November 9, 2012
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra studyL Schneider, N Ktorza, S Fourati, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2019
Long-term follow-up of HIV-infected patients on dolutegravir monotherapyG Tebano, C Soulié, L Schneider, et al.
Infection|October 25, 2013
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity scoreF Caby, L Schneider, C Blanc, et al.
European Journal of Biochemistry|October 3, 1999
Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesisI Tacken, H Dahmen, O Boisteau, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2016
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemiaC Katlama, C Soulié, F Caby, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2014
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept studyS Seang, S Fourati, Y Keita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 8, 2015
Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trialR Ostan, M C Béné, L Spazzafumo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patientsF Bertucci, P Finetti, H Roche, et al.
Pageof 20

Showing results (181-190 of 195) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|July 8, 2000
A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinomaP Rougier, A Adenis, M Ducreux, et al.
HIV Clinical Trials|November 9, 2012
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra studyL Schneider, N Ktorza, S Fourati, et al.
The Journal of Antimicrobial Chemotherapy|December 5, 2019
Long-term follow-up of HIV-infected patients on dolutegravir monotherapyG Tebano, C Soulié, L Schneider, et al.
Infection|October 25, 2013
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity scoreF Caby, L Schneider, C Blanc, et al.
European Journal of Biochemistry|October 3, 1999
Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesisI Tacken, H Dahmen, O Boisteau, et al.
The Journal of Antimicrobial Chemotherapy|June 12, 2016
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemiaC Katlama, C Soulié, F Caby, et al.
The Journal of Antimicrobial Chemotherapy|July 25, 2014
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept studyS Seang, S Fourati, Y Keita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 8, 2015
Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trialR Ostan, M C Béné, L Spazzafumo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patientsF Bertucci, P Finetti, H Roche, et al.
Pageof 20